Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis

Current Opinion in Pulmonary Medicine
Felix Ratjen


While Pseudomonas aeruginosa continues to be the major pathogen in cystic fibrosis lung disease, there is increasing evidence that antibiotic therapy initiated early after the onset of infection is an effective strategy to postpone chronic P. aeruginosa infection. There are also studies showing that early treatment can eradicate the organism in the majority of cases. While comparative data for different treatment strategies are currently lacking, inhaled antibiotic therapy alone or in combination with ciprofloxacin has been shown to be efficacious. So far eradication of P. aeruginosa has not been associated with an increased risk of airway infection with other pathogens, but these studies have been performed in small cohorts. Additional information is also needed to clarify the optimal form and duration of therapy. Currently, there are two large studies ongoing to resolve some of these issues. There is sufficient evidence that early antibiotic therapy against P. aeruginosa can clear the bacteria from the respiratory tract. While the negative effects of chronic P. aeruginosa infection are well documented, long-term benefits of this intervention on lung function is lacking. Observational studies suggest, however, that early inter...Continue Reading


Aug 1, 1991·The American Review of Respiratory Disease·B W RamseyK Harris
Jul 1, 1989·Archives of Disease in Childhood·G SteinkampH von der Hardt
Oct 1, 1987·Journal of Clinical Microbiology·A E HollsingB Strandvik
May 1, 1986·The Journal of Pediatrics·J Levy
Jan 3, 2001·The Journal of Infectious Diseases·J L BurnsB W Ramsey
Feb 17, 2001·Pediatric Pulmonology·F RatjenUNKNOWN German Board of the European Registry for Cystic Fibrosis (ERCF)
May 4, 2001·The European Respiratory Journal·J P GutierrezP D Phelan
Apr 16, 2002·The Journal of Pediatrics·Harris R StutmanMelvin I Marks
Jun 8, 2002·JAMA : the Journal of the American Medical Association·Susan E H WestPhilip M Farrell
Dec 14, 2002·American Journal of Respiratory and Critical Care Medicine·Ronald L GibsonUNKNOWN Cystic Fibrosis Therapeutics Development Network Study Group
Feb 28, 2003·Lancet·Felix Ratjen, Gerd Döring
Mar 12, 2003·Pediatric Pulmonology·Ranjan SuriAndrew Bush
Oct 14, 2003·American Journal of Respiratory and Critical Care Medicine·Ronald L GibsonBonnie W Ramsey
Feb 3, 2005·JAMA : the Journal of the American Medical Association·Zhanhai LiMark L Splaingard
Sep 2, 2005·The European Respiratory Journal·G TaccettiG Döring
Apr 22, 2006·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Lea BenturDrora Berkowitz

❮ Previous
Next ❯


Jan 17, 2014·The Lancet. Respiratory Medicine·Hartmut Grasemann, Felix Ratjen
Mar 16, 2012·Interactive Cardiovascular and Thoracic Surgery·Ryo MiyataHiroshi Date
Mar 6, 2009·Journal of Clinical Microbiology·Timothy J KiddUNKNOWN ACPinCF Investigators
May 28, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Valerie Waters
May 15, 2015·Expert Opinion on Therapeutic Patents·Hong Yang, Tonghui Ma
Oct 11, 2008·Expert Review of Vaccines·Ulrich Baumann
Aug 1, 2008·Expert Review of Respiratory Medicine·Stanley B Fiel
Feb 25, 2009·Expert Opinion on Drug Metabolism & Toxicology·Maria F Wolf, Arne Simon
Jun 18, 2011·The Medical Clinics of North America·Luke F Chen, Donald Kaye
Nov 17, 2009·Infectious Disease Clinics of North America·Luke F Chen, Donald Kaye
Mar 29, 2011·Letters in Applied Microbiology·S U SavelevA De Soyza
Oct 17, 2009·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Edith T ZemanickFrank J Accurso
Sep 3, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G A Tramper-StrandersT F W Wolfs
May 6, 2015·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Pieter C GoeminneLieven J Dupont
Sep 27, 2013·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Luiz Vicente Ribeiro Ferreira da Silva FilhoJosé Dirceu Ribeiro
Nov 3, 2016·The Cochrane Database of Systematic Reviews·Kate H Regan, Jayesh Bhatt
Apr 28, 2009·Respiratory Care·Jane C Davies, Diana Bilton
Apr 19, 2019·The Cochrane Database of Systematic Reviews·Kate H Regan, Jayesh Bhatt
Dec 18, 2019·The Cochrane Database of Systematic Reviews·Sally PalserAlan R Smyth
Sep 22, 2011·Chemical Communications : Chem Comm·Chi-Kin KooEric T Kool
Apr 18, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Dae-goon YooBalázs Rada
Nov 21, 2020·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Jane ChoiRohan Thompson

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.